Table 2.
Baseline (t0) |
2 weeks follow-up (t1) |
3-months follow-up (t2) |
||||||
---|---|---|---|---|---|---|---|---|
N | Mean (SD) | N | Mean (SD) | N | Mean (SD) | Estimated difference in change between T0 and T2 (90% CI) | P-value two-way interaction | |
Patient activation (PAM) | 0·56 | |||||||
Intervention | 65 | 55·6 (11·5) | 65 | 55·1 (12·5) | 59 | 56·4 (11·7) | 1·8 (-1·0 to 4·7) | |
Control | 68 | 55·1 (11·5) | 68 | 54·7 (9·8) | 61 | 54·7 (11·6) | ||
General self-efficacy (GSE) | 0·23 | |||||||
Intervention | 69 | 29·5 (5·5) | 67 | 29·5 (5·4) | 60 | 30·0 (5·7) | 1·0 (-0·2 to 2·2) | |
Control | 69 | 31·1 (4·5) | 68 | 29·9 (4·6) | 62 | 30·6 (4·3) | ||
HRQOL (EORTC-QLQ-C15-PAL) | ||||||||
Global quality of life | 0·69 | |||||||
Intervention | 69 | 73·9 (18·8) | 67 | 69·9 (18·2) | 60 | 70·3 (21·3) | -2·6 (-7·5 to 2·4) | |
Control | 69 | 73·4 (18·4) | 68 | 70·6 (22·5) | 62 | 72·6 (18·9) | ||
Physical functioning | 0·23 | |||||||
Intervention | 69 | 88·1 (14·4) | 67 | 88·2 (13·4) | 60 | 87·0 (15·2) | -0·8 (-4·3 to 2·6) | |
Control | 69 | 90·3 (16·3) | 68 | 87·6 (18·5) | 62 | 88·7 (18·4) | ||
Emotional functioning | 0·32 | |||||||
Intervention | 69 | 71·7 (24·3) | 67 | 74·9 (22·4) | 60 | 71·9 (26·3) | 4·6 (-1·0 to 10·1) | |
Control | 69 | 81·2 (21·0) | 68 | 81·1 (20·7) | 62 | 77·7 (22·2) | ||
Fatigue | 0·27 | |||||||
Intervention | 69 | 45·4 (28·0) | 67 | 42·0 (24·7) | 60 | 44·4 (28·6) | -3·2 (-9·8 to 3·4) | |
Control | 69 | 35·7 (25·6) | 68 | 39·0 (30·1) | 62 | 37·9 (27·7) | ||
Pain | 0·54 | |||||||
Intervention | 69 | 27·5 (28·1) | 67 | 27·9 (24·3) | 60 | 29·4 (27·3) | 2·6 (-3·7 to 8·9) | |
Control | 69 | 22·9 (25·3) | 68 | 25·2 (26·5) | 62 | 24·2 (27·1) | ||
Dyspnea | 0·32 | |||||||
Intervention | 69 | 19·3 (23·2) | 67 | 22·4 (25·5) | 60 | 21·1 (25·3) | 4·7(-1·3 to 10·6) | |
Control | 69 | 19·3 (25·8) | 68 | 17·6 (26·7) | 62 | 15·6 (25·4) | ||
Insomnia | 0·91 | |||||||
Intervention | 69 | 33·3 (31·8) | 67 | 31·3 (30·6) | 60 | 32·2 (28·1) | 0·4 (-7·1 to 7·9) | |
Control | 69 | 29·5 (30·0) | 68 | 28·9 (28·7) | 62 | 25·8 (29·8) | ||
Appetite loss | 0·66 | |||||||
Intervention | 69 | 22·2 (30·6) | 67 | 19·4 (30·2) | 60 | 21·7 (29·3) | -2·3 (-10·2 to 5·6) | |
Control | 69 | 18·4 (26·5) | 68 | 20·1 (29·4) | 62 | 22·0 (29·5) | ||
Nausea | 0·68 | |||||||
Intervention | 69 | 18·8 (30·0) | 67 | 13·9 (24·0) | 60 | 20·6 (28·2) | 2·8 (-5·6 to 11·2) | |
Control | 69 | 18·8 (24·6) | 68 | 15·7 (27·3) | 62 | 18·3 (26·8) | ||
Constipation | 0·48 | |||||||
Intervention | 69 | 24·2 (27·3) | 67 | 20·9 (25·8) | 60 | 22·2 (26·5) | -5·8 (-14·0 to 2·3) | |
Control | 69 | 18·8 (21·8) | 68 | 19·1 (27·8) | 62 | 21·5 (29·0) |